Comment from Otsuka Pharmaceutical Development & Commercialization, Inc.

Summary: Otsuka Pharmaceutical Development & Commercialization, Inc. expresses support for the draft guidance regarding the Common Technical Document for the registration of pharmaceuticals. They suggest specific improvements, such as clarifying the inclusion of raw materials like processing aids and requesting a transition period for industry compliance.